Kidney Cancer Association

In 2011, Thai Ho, M.D., Ph.D. of Mayo Clinic Scottsdale was a recipient of the ASCO Conquer Cancer Foundation Award. The grant was funded by the Kidney Cancer Association. Dr. Ho studied the role of SETD2, a histone methyltransferase, in the development of renal cell carcinoma. Dr. Ho identified errors that initially arise in early kidney cancer, which lead to propagation of these same errors in metastases. He and his team continue to focus on the epigenetics of these alterations in kidney cancer metastases. Dr. Ho has started treating patients affected by kidney cancer with drugs that target these epigenetic errors propagated in metastases. “Unlike other cancers, there are no screening tests for kidney cancer, and once kidney cancer has spread, patients lose on average, 12 years of life. Furthermore, there is less research funding dedicated to kidney cancer, when compared to other cancers. Kidney cancer research funding attracts new investigators to the field, gives them an opportunity to take a high scientific risk, and potentially use kidney cancer as a paradigm for the treatment of other cancers,” Dr. Ho said. To help fund more breakthroughs in kidney cancer research, follow this link to make a contribution: bit.ly/2TBr8Jr

Get your FREE orange ribbon here! bit.ly/2tQnoW1
Please note: only one ribbon will be sent out per address.